Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children

                   
prnewswire.com     May 13, 2008            

Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children NEW ROCHELLE, N.Y., May 13 /PRNewswire/ -- Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic... [read full story]                    

Full Coverage
                   

NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease

eurekalert.org     May 13, 2008          

Promising results from a team of NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis, a rare, genetic, degenerative...                    

comments

                   

Clinical trial yields promising results for Batten disease

emaxhealth.com     May 13, 2008          

Innovative therapy is safe and slows Batten disease progression. Promising results from a team of NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile...                    

comments

                   

Gene Therapy Clinical Trial Yields Promising Results for Batten Disease

newswise.com     May 13, 2008          

Promising results from a team of NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL), a rare, genetic, degenerative...                    

comments

Gene Therapy Clinical Trial Yields Promising Results For Batten Disease

sciencedaily.com     May 13, 2008          

Promising results from a team of physician-scientists show that gene therapy is both safe and effective at slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis, a rare, genetic, degenerative neurological disorder that usually becomes fatal in children by the...                    

comments

                   

Gene therapy slows progression of fatal neurodegenerative disease in children

eurekalert.org     May 13, 2008          

Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue of Human Gene...                    

comments

                   

Gene therapy slows progression of fatal neurodegenerative disease in children

physorg.com     May 13, 2008          

Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue (Vol. 19 No. 5) of...                    

comments

                   

Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children

redorbit.com     May 13, 2008          

NEW ROCHELLE, N.Y., May 13 /PRNewswire/ -- Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of...                    

comments

                   

Therapy Yields Promise for Fatal Neurological Condition

healthcentral.com     May 13, 2008          

TUESDAY, May 13 (HealthDay News) -- A new gene therapy that involves injecting a harmless virus into the brain shows promise as a safe and effective way to slow Batten disease, a rare neurological disorder that usually becomes fatal between the ages of 8 and 12. Children with the disease, also...                    

comments

                   

Promising Gene Therapy For Rare Brain Disease

redorbit.com     May 13, 2008          

Posted on: Tuesday, 13 May 2008, 12:55 CDT A recent study conducted by US researchers revealed that gene therapy could result in recession of a rare neurological disorder in children. Although lead researcher Dr. Ron Crystal of New York-Presbyterian Hospital/Weill Cornell Medical Center said the...                    

comments

                   

Therapy Yields Promise for Fatal Neurological Condition

kltv.com     May 14, 2008          

TUESDAY, May 13 (HealthDay News) -- A new gene therapy that involves injecting a harmless virus into the brain shows promise as a safe and effective way to slow Batten disease, a rare neurological disorder that usually becomes fatal between the ages of 8 and 12. Children with the disease, also...                    

comments

1 2 next